A Study To Investigate The Pharmacokinetics, Pharmacodynamics, Safety And Tolerability Of Single Dose Vupanorsen In Healthy Chinese Adults
Clinical trial NCT04916795 · COMPLETED
Trial details
- NCT number
- NCT04916795
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-17
- Primary completion
- 2021-10-19
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.